HomeNECLIFE • NSE
add
Nectar Lifesciences Ltd
Previous close
₹17.60
Day range
₹17.01 - ₹17.80
Year range
₹15.51 - ₹56.50
Market cap
3.91B INR
Avg Volume
4.71M
P/E ratio
-
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 4.29B | -2.59% |
Operating expense | 963.95M | -1.78% |
Net income | -1.30B | -22,059.69% |
Net profit margin | -30.33 | -23,430.77% |
Earnings per share | — | — |
EBITDA | -1.54B | -412.42% |
Effective tax rate | 30.68% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 197.51M | -2.71% |
Total assets | 20.47B | -6.56% |
Total liabilities | 10.91B | -2.74% |
Total equity | 9.56B | — |
Shares outstanding | 224.29M | — |
Price to book | 0.41 | — |
Return on assets | — | — |
Return on capital | -26.20% | — |
Cash Flow
Net change in cash
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -1.30B | -22,059.69% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1995
Headquarters
Website
Employees
1,686
